TPNI yields 2000000.00% · ABBV yields 3.06%● Live data
📍 TPNI pulled ahead of the other in Year 1
Combined, TPNI + ABBV cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of TPNI + ABBV for your $10,000?
The Pulse Network, Inc. provides a cloud-based platform that focuses on content marketing and event solutions in the United States. It operates a cloud-based content marketing platform, which enables corporate marketers and event groups in their campaign efforts. The company's platform includes Content Marketing Platform that provides newsletters for outreach and engagement; Digital Publication Platform Creator, which develops digital publications; Video Webcast Production Platform that engages the audience with live video production, and enhances participation with live polls and chats; and Event Management Platform, which creates interactive customer experiences through registration and online engagement. Its platform also enhances registration counts through engagement and social sharing, and verification counts through connecting with the audience. In addition, the company offers ICTG platform, a marketing and follow up automation software; event management solution, an end-to-end tool for event groups worldwide; and HostMyLeads.com for lead management, as well as event technology, registration, lead generation, Web, and lead management program services for businesses, event organizers, and associations to engage with their community across channels, such as online, mobile, or face to face. Further, it provides Event Database Solutions comprising a multi-channel software-as-a-service platform for marketing support, registration, housing, management reporting, lead retrieval, online production, event Websites, and continuing education unit tracking, as well as services for marketing and event management. Additionally, the company offers content marketing tools that include syndication and distribution, social sharing, newsletter creation, analytics and reporting, prospect management, and other tools, as well as a content curation tool, which support the cloud-based platform. The Pulse Network, Inc. was founded in 1994 and is based in Norwood, Massachusetts.
Full TPNI Calculator →AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Full ABBV Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.